Logo image of CHSCN

CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis

NASDAQ:CHSCN - Nasdaq - US12542R5063 - Currency: USD

25.49  -0.09 (-0.35%)

Fundamental Rating

3

CHSCN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 91 industry peers in the Food Products industry. CHSCN has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHSCN is valued expensive and it does not seem to be growing. CHSCN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CHSCN had a positive operating cash flow in the past year.
Each year in the past 5 years CHSCN has been profitable.
In the past 5 years CHSCN always reported a positive cash flow from operatings.
CHSCN Yearly Net Income VS EBIT VS OCF VS FCFCHSCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

CHSCN's Return On Assets of 2.88% is in line compared to the rest of the industry. CHSCN outperforms 54.95% of its industry peers.
With a Return On Equity value of 5.40%, CHSCN perfoms like the industry average, outperforming 51.65% of the companies in the same industry.
CHSCN has a Return On Invested Capital (0.47%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHSCN is significantly below the industry average of 28.19%.
The 3 year average ROIC (6.11%) for CHSCN is well above the current ROIC(0.47%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.88%
ROE 5.4%
ROIC 0.47%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCN Yearly ROA, ROE, ROICCHSCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.61%, CHSCN perfoms like the industry average, outperforming 48.35% of the companies in the same industry.
In the last couple of years the Profit Margin of CHSCN has grown nicely.
CHSCN has a worse Operating Margin (0.25%) than 60.44% of its industry peers.
In the last couple of years the Operating Margin of CHSCN has declined.
CHSCN has a Gross Margin of 3.40%. This is amonst the worse of the industry: CHSCN underperforms 86.81% of its industry peers.
In the last couple of years the Gross Margin of CHSCN has remained more or less at the same level.
Industry RankSector Rank
OM 0.25%
PM (TTM) 1.61%
GM 3.4%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCN Yearly Profit, Operating, Gross MarginsCHSCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

More info and screens

3

2. Health

2.1 Basic Checks

CHSCN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The debt/assets ratio for CHSCN is higher compared to a year ago.
CHSCN Yearly Shares OutstandingCHSCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCN Yearly Total Debt VS Total AssetsCHSCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CHSCN has an Altman-Z score of 2.19. This is not the best score and indicates that CHSCN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.19, CHSCN is in line with its industry, outperforming 52.75% of the companies in the same industry.
CHSCN has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.33, CHSCN is doing good in the industry, outperforming 60.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 2.19
ROIC/WACC0.1
WACC4.75%
CHSCN Yearly LT Debt VS Equity VS FCFCHSCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCN has a Current Ratio of 1.43. This is a normal value and indicates that CHSCN is financially healthy and should not expect problems in meeting its short term obligations.
CHSCN has a Current ratio (1.43) which is comparable to the rest of the industry.
CHSCN has a Quick Ratio of 1.43. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCN has a Quick ratio (0.74) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.74
CHSCN Yearly Current Assets VS Current LiabilitesCHSCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

Looking at the last year, CHSCN shows a very negative growth in Revenue. The Revenue has decreased by -14.58% in the last year.
The Revenue has been growing slightly by 4.24% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-14.58%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%-14.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCN Yearly Revenue VS EstimatesCHSCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCN Price Earnings VS Forward Price EarningsCHSCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CHSCN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHSCN is cheaper than 95.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.41
CHSCN Per share dataCHSCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.36%, CHSCN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.68, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 91.21% of the companies listed in the same industry.
CHSCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 7.36%

5.2 History

CHSCN has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
CHSCN Yearly Dividends per shareCHSCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCN pays out 29.24% of its income as dividend. This is a sustainable payout ratio.
DP29.24%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Yearly Income VS Free CF VS DividendCHSCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCN Dividend Payout.CHSCN Dividend Payout, showing the Payout Ratio.CHSCN Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 7.1 PERP

NASDAQ:CHSCN (8/1/2025, 8:00:00 PM)

25.49

-0.09 (-0.35%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-09 2025-07-09
Earnings (Next)11-04 2025-11-04
Inst Owners11.61%
Inst Owner Change-91.8%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap312.76M
Analysts0
Price TargetN/A
Short Float %0.14%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 7.36%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP29.24%
Div Incr Years0
Div Non Decr Years10
Ex-Date06-13 2025-06-13 (0.44375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.93
P/B 0.03
P/tB 0.03
EV/EBITDA 3.41
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-39.36
FCFYN/A
OCF(TTM)27.55
OCFY108.07%
SpS2923.63
BVpS872.78
TBVpS872.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 5.4%
ROCE 0.67%
ROIC 0.47%
ROICexc 0.47%
ROICexgc 0.47%
OM 0.25%
PM (TTM) 1.61%
GM 3.4%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexcg growth 3Y38.36%
ROICexcg growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 5.23
Cap/Depr 137.98%
Cap/Sales 2.29%
Interest Coverage 250
Cash Conversion 49.42%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.74
Altman-Z 2.19
F-Score3
WACC4.75%
ROIC/WACC0.1
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.58%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%-14.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-91.26%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-117.21%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-89.65%
OCF growth 3Y18.88%
OCF growth 5Y2.23%